CliffBio
small molecule

AMINOSOL 5%

PROTEIN HYDROLYSATE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameAMINOSOL 5%
Active ingredientPROTEIN HYDROLYSATE
Strength5%
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJanuary 1985
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

AMINOSOL 5% patent cliff — loss of exclusivity — | CliffBio